Not on OTC. It trades under ticker TBPMF.

21 months ago CEO told on video 2 major stories. One was for Reduvo for which they applied 28 (!!!) Months ago for market access. 28 months!! What's wrong??? No info!!!

18 months ago he told us they started with FDA a Reborn trial which should replace Opioid for pain control. 18 months not 1 single info.

Trading halted or not, it is a dead beaten dog. Such simple company without business can't get an commercial audit done? Before i bought shares info's were flowing. Results were very promising and I thought we
have a solution for the Opiod Crisis.

I was wrong! Take care!

The 2 years for Reduvo are now completed. A simple drug approval takes in Canada 2 years and no end in sight.
The Reborn trial completed 1, 5 years without any comments and results. Is the trial still running or has it been stopped?

They got recently about 10 Mio$ as a loan. For what?

We get a not atypical question from Health Canada. If a risk management plan is not atypical, why haven't we delivered such plan not 2 years ago? Now we don't have such plan otherwise we would have provided it already 2 years ago. I have no idea how complex such plan is, but we can assume they will need at least 1 months and then.....

We end up March 23.
What professionals are these guys? Shame on them!! 2 years sleeping on the shelf and another round and then another??
And Reborn? Is it dead? 18 months no info!!

Good, if you are happy with bla bla pr. Since June 22 we got nothing with any substance. 2 years - no Reduvo- approval. 1,5 years no info about Reborn trial.
The only positive, I can take, is the loan we got from a good longterm investor. They are not giving tetra a huge loan without promising background info.

While the previous CEO, Nader, had a great drug but moved forward like a professional scammer and burned down our great chances for HIV and COVID, the new future CEO is of a different calibre. He keeps quiet most of the time- good, but not good enough! A few days ago, the last information was excellent and confirmed with possible certainty by top external doctors that the drug has a great future for many, if not countless, diseases. All the available results are great - of course, from a formal view, not good enough for approval any time soon, in fact, years away.

Unfortunately, at the end of the call, unnecessary info about the "FDA- hold" and partnerships was released, which gives shorters a clear timeline about their timeframe for continuous shorting. I thought Cyrus would have learned his lessons in the past- obviously not. Shorters and MMs are starting to love him. This was unnecessary favour for them.

We don't need info about the following:
* Amarex: we know they will pay when the time comes. The announcement will come as a surprise.
* FDA- Hold: time will come, maybe in 4 weeks, maybe in 2 months. No need to talk about it. The "hold" will be released. keep quiet.
* Partnership: will come for Oncology, the last info gives me a 100% certainty. We know it will not happen before lifting the "Hold"

I believe it will take us to mid of February before we will see sp moving up again - in the meantime shorters will play us with pleasure as president is talking too much about timelines.

Perfectly right and correct and I fully agree, but there is one major mistake: FDA gives a sh.t on lives. Never cared and never will care. FDA is the organisation to protect Big Pharma to make money. BP pays 45% of FDA'S budget.

What kind of clowns are in Canada Health? They need 2 years to bring 1 question foreward and then the delinquent has to answer within 2 days. If correct, then its a good joke.

Great, after 23 months the first question. How long will it take for the second question? At least one started to read the application. See you end of 2023? Bravo Canada Health - it is alive!!

Does anyone know more about the financing by Alpha Blue Ocean? Why should one a "dead cat" borrow money without interest, or at all? Credit convertible into worthless shares? Getting worthless warrants for 0,035$? No one would ever do so unless he/she knows Reborn is becoming a winner.
Tetra already knows very well whether Reborn is a success or not but has obviously problems filling the trial, or FDA makes some problems as usual for tiny biotechs.

Maybe TETRA will still become a winner. Reborn works, but that doesn't mean that TETRA will succeed; too many enemies are waiting to eat it.

Reduvo has some importance, but those who invested in Tetra are not here because of Reduvo but for the reborn success. Reborn is the key for tetra, Reduvo is just a tiny matter of support, but even this didn't come along in 23 months.

Any clue where Reborn is after 16 months?

Here is my letter, which didn't get any reply:

Dear Natalie,

I hope you are in a much better condition than Tetra. I wonder what you think you can tell me:

Initially, your CEO was expecting the Reduvo approval for latest end of 2021. I checked in the meantime the performance of Health Canada and found that in the worst case, the approval process for a drug took 24 months. We will reach the worst case, 24 months, in December 2022. Does your company know that we will even be the new record and take longer than 24 months?
The intermediate results for Reborn - FDA trial- were planned for June 22. You modified the trial twice to be faster than initially seen. We are now 16 months into the trials without any report for results. The performance of Reborn can be seen daily, but no indications are given about enrollment (done or not?) and performance (within expectations or not).

We are approaching the last resistance before we fall over the cliff down to 0.006. Does the CEO want us to fall over the cliff? I trust, Reborn is working, but maybe you can't manage the enrollment. Perhaps something went very wrong?
Maybe the CEO feel burnt after all his promises last year in June failed so dramatically. Even if he doesn't want anymore give predictions some info could keep us alive such following messages:

We still wait for the approval. So far no negative indications that it will not take place.
The Reborn trial is smoothly running; enrollment is very slow, but we have managed so far xy %. After complete enrollment, it will take us another xy months for results.

I think your CEO should consider that people like me and many others invested in Tetra based on excellent preliminary results. We need to come back to a climate of hope and trust.

Could you please let your CEO know?

kindest regards

I was writing twice to the company. No reply. I was calling, no one takes phone. Conclusion? Soon they will delist - they are dead and we need opiate for the pain.
Happy bagholding.

We are in the Pharmaland of crime, fraud, corruption. We play accordingly or we are out. Complaining doesn't help. Paying the membership fee and become one of them is the solution.The game against them we will never win. Government, Senate, Congress, FED, FDA, NHIA, FBI, SEC, CIA, Pentagon,....all corrupt. This is their very successful business model.

We are approaching several milestones:
1) soon we have 2 years completed for waiting for Reduvo approval. CEO is speechless!
2) soon we will be back at alltime low 0.01. CEO is paralyzed!
3) soon Reborn trial is running 18 months. Is it running at all? CEO provides no information.
4) no information about projects and joint ventures? CEO doesn't care about TBP otherwise he would at least try to build trust and confidence with the shareholder. Or?? Does he have an other agenda?
With the little knowledge of today, I would trust the medicine, but no way to trust management. No way to trust that any medicine gets approved despite its performance as opioid makes too much money. Who cares on suffering or dead people as long as BP makes Billions $.
Only sick people are good for business. Death is collateral damage, part of business.

In 3 months we have the 24 months completed. Bravo Canada Health. Another crooked organisation. Never approve something what helps people. The same story like with FDA

New terms and first closing of financing with Alpha Blue!

Apart from the increase of the financing volume from 6 to 10 Mio $, the following sentence seems to me to be indirect info:
"The Company intends to use the net proceeds of the Financing to finance the manufacturing costs of its QIXLEEF drug candidate."

Is this a hint that Reduvo approval is finally coming? Is this the reason for increasing the volume from 6 to 10 Mio$?

Thank you for sharing this video.

We all hear and know about Opioide crisis. We have heard extremely promising first results of the Tetra product. It will in many years find its way to the market. Not much doubt.

I am with Leronlimab for more than 5 years. Every expert knows how phantastic this drug works for Covid, Cancer, HIV, TNBC, NASH and many other diseases. It was successful in Phase3 and 2 trials. And? No way to find its way to the market. Big Pharma will not allow to get its business destroyed and FDA collaborates perfectly.

Let's look at Tetra's Reborn trial. It runs for more than 1 year and Tetra has even not reported interim results. There is no way to bypass BP. FDA will find ways to delay for many years, no matter how great Tetra's products are working.

Whatever Gay told us in June 21 was wrong. Yes, the Tetra product is working and is needed desperately but BP will not allow to get it to market. Maybe the new JV can help but still it will take many years.

I invested 2021 because Reborn trial and coming PIN. I was wrong like with Leronlimab. In both my investments were years too early. Gay does what Nader did - telling not the whole true story about great medicine.

We continue to get served one Nothingburger after the other one. Many "news", but all are irrelevant. What is relevant? We know it:

X) PIN for Reduvo! Why don't we hear anything about it? The approval process already takes 20 months, and no update.
X) What is with Reborn going on? Guy promised us for June 22 interim results. The trial started on June 21. We are in the 15th month, and no results? Is it running at all?

Guy had a big mouth on June 21, but then he disappeared and sent us unimportant Nothingburgers. What is going on?

Reduvo: dead, no approval for 20 months. Guy a liar or Canada Health a joke or one gas other ideas?
Reborn: intermediate results were planned for June. Trial has been running now for 15 months.
I believe the drug is working, no big doubts, but maybe FDA not interested. People make too much much money with Opiates. Delays might be wanted and more to come. To get participants fot the trial is another big issue.

In Germany doctors get paid when they prescribe Paxalovid; maybe BP pay also doctors for prescribing Opiates? Pharma Industry is a too crooked mafia business.

There are always irresponsible guys or guys with particular agendas that create hypes, and then people get the setback to reality. We haven't had to expect great news coming out with this recent 10Q. We know all the good and bad matters about our current situation. Nothing has changed.
We are inching daily with the new management to the deserved success of the great drug Leronlimab. We have known the roadblock for many months. Nader was one and got removed. The several battles with bad guys we won (e.g. Pestell, 13D Group). In Amarex's case, we will win - maybe it will take another 4 to 6 months. FDA will once stop to block us as the data are just overwhelming significant. BLA will be once managed, poorly done in the past; it will take another few months. SEC and DOJ will disappear with nothing. Our trial results in the pipeline will blow many people's minds away. BP know it and is therefore fighting against us, but some will join us, and with 350 Mio shares more, we will be ready as well.
I don't expect, with this many roadblocks, a fast solution, but we will grind up, and the near-term partnerships will make us take off like a rocket.
Don't worry, be patient. Maybe our time is September, October, but not later than November 22.

Does this bs never stops? They could find at least new stories.

20 months since company applied for DIN. That's the way how "health organisations" exhaust small Biotecs to death.

Reborn trial? Not a failure but the next never ending stories. Results were promised for June.

When and How do such stories end? When BP get them for less than a breakfast. Corruption, even Mafia was better.

https://spharm-inc.com/the-drug-review-and-approval-process-in-canada-an-eguide/

According to this information, Canada's regulatory approval process takes 0,5 to 2 years. How could Guy tell us the approval process for DIN would take us to the end of 2021?

The excellent message: Relax, only anymore 5 months until approval.

Maybe Health Canada comes up with other excuses? How about Monkeypox?

By the way, in this article it is written that Canada has by far the slowest process for approving; far behind FDA, MHRA, and EMA.

We are waiting for Reborn.

Reduvo is a side battlefield which would have given us some income, but after 19 months of waiting, I doubt it will ever come. Something went wrong.

First Reborn trial results were promised for June 22. Maybe also this is considerably delayed. They got problems with patient recruitment.

The CEO seems to have nothing under control.

I expected the approval of Reduvo by end of 2021. Some were saying it will come at the end of March 22. Canada Health are sleeping or we have an unreported problem with Reduvo. NOW soon 19 months gone since application.

I was hoping we get in June 22 some interim results about the Reborn trial. It seems that trial is delayed as well.

What is left? Hope! It dies as the last. Not a good strategy.

Thank you. Great summary.

Great science. Poor management. How can I have a great science and not being able to get it sold? The publication for which we wait one year and might never come will change everything? That is the plan?

Talk as the day and year is long, this management has no plan and is hopless helpless. 1.5 years on high sea without navigation. What a sad drama.

This cooperation is an indirect confirmation that trials are promising. Finally something with substance.

The Big Boys are the Big Shorters. What reason should they have to let it go? This will only go up if ever forced. But, who can force them? They make the rules of the game. SEC is a fake. Big Boys are real.

It is waiting for approval for 19 months. Is this alive?

Reduvo is dead. What a scam.
Reborn was supposed to deliver results in June 22. Is it the next scam?
Fact is that Canada Health, FDA and EMA are protecting Big Pharma.

Covid, the perfect excuse for everyone. How comfortable to blame the virus for the own lack of capabilities.
Canada Health by the way is my opinion the same Mafia like FDA with the target help big pharma and kill small biotechs.
Who cares of pain? Who cares of people's health and lives? Not any of all these corrupted organisations. They keep us at bay until 2023 or even 2024. Until last shareholder left, then the patents become free lunch for Pfizer & Co. Always the same.

Do you really believe that? Crime always prevails, especially in stock markets.

They plan to do maybe the same like they did with NWBO 2 weeks ago. Everybody expected great results. The MM drove the price from 0.8 to 2$ within few days. Then in minutes to 0.6$.
I think the same might happen here. No stop losses.
Stock market is just brutal crime.

PS. By the way, NWBO had great results, but who cares on great results in this manipulated world? Everything is fake!!

When the company fears to release the great results then we have to wait until FDA gives an approval and then accepts BLA. That might take another 12 months.
Maybe peer reviewed article in journal also not safe enough fighting against the crook? Maybe such article takes also at least another 6 months.
In my experience, conferences are not helping the share price.
I understand the results are great and the company fears for good reason the crook AF.

So what? 2023!

What a joke! 18 months ago we applied for DIN, now we have discussions with authorities? 18 months and no DIN for Reduvo? After 12 months no results about Reborn? But, distracting activities and pr continue. Now new company in Australia. One company here, another one there. We covering Nord- and South America, we cover Europe, Asia and now Australia. But we have no drug for sale. Great!!!

Does anyone believe REDUVO will ever get an approval? CEO never tells us what is wrong.

Reduvo is at least four months overdue with approval from Canada Health. I guess and hope now that we get an update about Reborn instead in the month of July.

Reborn is ten times more important and is the reason we are here.

Canada Health is another highly underperforming institution. If the FDA of the USA will play by exception fair with Tetra will be a different story as Woodcrook said in public that she doesn't like small pharma. She prefers Big Pharma with a lot of money. The FDA- system kills small pharma to enable Big Pharma to get the small companies on the silver plate.

Overall, maybe in July something positive. Until then try to survive.

According to Linkedin regarding new accountant firm:

One of the fastest growing professional services firms in the U.S., MGO combines deep industry expertise with proven accounting and advisory solutions to deliver tangible results. Our clients range from global aerospace and technology leaders to innovative start-ups and not-for-profit organizations – from the largest government entities in the country, to the biggest names in entertainment.

MGO is ranked as one of the top CPA firms in the nation by Accounting Today and Inside Public Accounting. And the firm was awarded the ‘Best of Accounting’ designation in Client Satisfaction by the independent research firm, Inavero.

To find out more about MGO, visit our website at www.mgocpa.com